Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and … AI Abushouk, H Ahmed, A Ismail, A Elmaraezy, AS Badr, M Gadelkarim, ... Rheumatology international 37 (7), 1053-1064, 2017 | 22 | 2017 |
Meta-analysis of creatine for neuroprotection against Parkinson’s disease A Attia, H Ahmed, M Gadelkarim, M Morsi, K Awad, M Elnenny, E Ghanem, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017 | 14 | 2017 |
Gene delivery of AAV2-neurturin for patients with Parkinson’s disease: A meta-analysis AG Almraezy, H Ahmed, M Elnenny, A Negida Movement Disorders. Berlin, Germany: International Parkinson’s and Movement …, 2016 | 1 | 2016 |
02.01 Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumour necrosis factor inhibitors: A systematic review … H Ahmed, AI Abushouk, A Ismail, A Elmaraezy, AS Badr, M Gadelkarim, ... Annals of the Rheumatic Diseases 76 (Suppl 1), A8-A8, 2017 | | 2017 |
Creatine for patients with Parkinson’s disease: A meta-analysis A Attia, H Ahmed, M Morsi, K Awad, M Elnenny, E Ghanem, A Negida MOVEMENT DISORDERS 31, S635-S636, 2016 | | 2016 |
DESMOTEPLASE FOR ACUTE ISCHEMIC STROKE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AG Almraezy, M Elnenny, H Ahmed, A Negida THROMBOSIS RESEARCH 141, S9-S9, 2016 | | 2016 |